Correlation between serum HE4 level and clinicopathological features of patients with endometrial cancer
Objective:To analyze the correlation between serum levels of Human epididymis protein 4(HE4)and clinicopathological features in patients with endometrial cancer.Methods:Clinical data of 120 patients with endometrial carcinoma admitted to hospital from January 2019 to June 2022 were retrospectively analyzed.All patients were treated with total hysterectomy.Clinicopathological data of patients were collected,and the level of HE4 in all patients was detected,and the correlation between serum HE4 level and clinicopathological features of patients with endometrial cancer was analyzed.Results:Among 120 cases of endometrial carcinoma,46 cases were endometrioid adenocarcinoma,36 cases were endometrioid clear cell carcinoma and 38 cases were endometrioid squamous cell carcinoma.Lymph node metastasis occurred in 35 cases and not in 85 cases.Infiltration depth of muscle layer:>1/2 muscle layer 40 cases,≤1/2 muscle layer 80 cases;TNM stages:Stage I(22 cases),stage Ⅱ(43 cases),stage Ⅲ(55 cases).The lesions were located in 55 cases of uterine floor,37 cases of uterine horn and 28 cases of cervical canal.There was no significant difference in serum HE4 level among patients with different pathological types,TNM stages and lesion locations.The serum HE4 level in patients with myographic infiltration depth>1/2 was higher than that in patients with myographic infiltration depth≤1/2,and the serum HE4 level in patients with lymph node metastasis was significantly higher than that in patients without lymph node metastasis(P<0.05).Logistic regression showed that the increase of serum HE4 level was a risk factor for the depth of muscle invasion>1/2 muscle layer in patients with endometrial cancer(OR>1,P<0.05).Elevated serum HE4 level was a risk factor for lymph node metastasis in patients with endometrial cancer(OR>1,P<0.05).Conclusion:The increase of serum HE4 level can aggravate the depth of myographic infiltration and promote lymph node metastasis in patients with endometrial carcinoma.
Endometrial cancerSerum human epididymal secretory protein 4Clinicopathological featuresCorrelation